Pharma may avoid worst-case drug pricing scenario as US elec...

Pharma may have avoided a worst case scenario amid the political upheavals in the US elections with the threat of tough drug price legislation lowered, with hawkish Democrats unlikely to wi

Gilead finally breaks its silence on remdesivir’s price

After weeks of speculation, Gilead Sciences has revealed its pricing plans for coronavirus drug remdesivir – and the rationale behind its decision.

‘Predatory’ drugmakers exploit FDA’s unapproved drug scheme;...

Trump proposes drug import plan to cut prices, ahead of impe...

Labour government would use compulsory licensing for expensi...

Democrats unveil price plan targeting 250 big-spend drugs